We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-22.93%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$539M
AUM Growth
-$196M
Cap. Flow
+$13.3M
Cap. Flow %
2.46%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$13.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$248M 45.93%
16,245,817
+849,701
+6% +$13.3M
TNYA icon
2
Tenaya Therapeutics
TNYA
$163M
$111M 20.53%
9,400,290
– –
RVMD icon
3
Revolution Medicines
RVMD
$43.7B
$85.4M 15.83%
3,347,245
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$30.8M 5.72%
175,251
– –
SRZN icon
5
Surrozen
SRZN
$282M
$28.3M 5.25%
627,653
– –
ORIC icon
6
Oric Pharmaceuticals
ORIC
$1.44B
$19.1M 3.53%
3,568,181
– –
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$17.3M 3.2%
172,373
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q1 2022 Portfolio in Review

As of Q1 2022, Column Group held 7 positions worth $539M, down 27% from $735M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group added most to NGM Biopharmaceuticals, Inc. Common Stock in Q1 2022, an estimated $13.3M increase.
  • Column Group's ten largest holdings make up 100% of its $539M portfolio in Q1 2022.
  • Column Group opened 0 new positions and closed 0 in Q1 2022.
  • Column Group's portfolio value fell 27% quarter-over-quarter to $539M.

Based on Column Group's 13F filing for Q1 2022, filed 16 May 2022.